Brequinar in combination with cyclosporine a inhibits islet xenograft rejection for up to 24 days: A study in the pig-to-rat model

Transplantation Proceedings

Volumn 32, Issue 5, 2000, Pages 1026-

  Wennberg, L ^a   Song, Z ^a   Wijkstrom M ^a   Zhang, J ^a   Bari, S ^b   Sundberg, B ^a   Groth, C G ^a   Korsgren, O ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BREQUINAR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BIOLOGICAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GRAFT REJECTION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SWINE; XENOGRAFT;

ANIMALS; BIPHENYL COMPOUNDS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; RATS; RATS, INBRED LEW; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0343457931     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01097-6     Document Type: Conference Paper

References (3)

1. Wallgren A.C., Karlsson-Parra A., Korsgren O. Transplantation. 60:1995;594.
2. Wennberg L., Karlsson-Parra A., Sundberg B., et al. Transplantation. 63:1997;1234.
3. Korsgren O., Sandler S., Landstrom A.S., et al. Transplantation. 45:1988;509.